AR/EDA2R rs1160312: What Your Genotype Means
The rs1160312 variant is an intergenic genetic marker located on the X chromosome within the AR/EDA2R locus. It is widely recognized in genomic research as one of the strongest signals associated with susceptibility to early-onset androgenetic alopecia, or male-pattern baldness.
What each genotype means
Increased hair loss risk
This genotype is associated with a higher statistical likelihood of developing androgenetic alopecia compared to the alternative allele. Because this variant is located in a region linked to androgen receptor signaling, it may influence hair follicle sensitivity to androgens. This is a complex trait influenced by many genetic and environmental factors, so this result should not be viewed as a definitive prediction of hair loss.
Carried by a significant portion of the population, with the A allele showing a minor allele frequency of approximately 0.40 in European populations.
Intermediate hair loss risk
Individuals with this heterozygous genotype show an intermediate statistical association with androgenetic alopecia compared to those with the homozygous risk genotype. The presence of one copy of the risk-associated allele suggests a moderate influence on the biological pathways regulating hair follicle health. As hair loss is a polygenic trait, this genotype is only one of many factors that contribute to an individual's overall risk profile.
This heterozygous combination is common in populations where the A allele is prevalent, reflecting the expected distribution of a variant with a 0.40 minor allele frequency.
Reduced hair loss risk
This genotype is associated with a lower statistical risk of developing androgenetic alopecia compared to carriers of the A allele. While this suggests a more favorable genetic profile regarding this specific locus, it does not guarantee protection against hair loss, which is influenced by numerous other genetic and non-genetic factors. Genetic associations are probabilistic and do not provide a clinical diagnosis.
This genotype is found in a substantial segment of the population, consistent with the frequency of the G allele in European ancestry groups.
Understanding the rs1160312 Variant
The rs1160312 variant is a single nucleotide polymorphism (SNP) situated on the X chromosome. It resides in an intergenic region between the androgen receptor (AR) gene and the ectodysplasin A2 receptor (EDA2R) gene. Because it is located in a non-coding region, it does not directly alter the protein sequence of these genes. Instead, researchers believe this variant may influence how these genes are regulated or expressed in the scalp. The AR gene is critical for androgen signaling, while EDA2R is involved in pathways that regulate hair follicle development and survival. By studying this specific location, scientists have identified a robust statistical link between certain alleles at this site and the likelihood of developing androgenetic alopecia, a condition characterized by the progressive thinning of hair follicles.
The Role of the AR/EDA2R Locus
The AR/EDA2R locus is a focal point in dermatological genetics because of its profound influence on hair growth cycles. The androgen receptor (AR) is the primary mediator of testosterone and dihydrotestosterone effects in the body. In individuals genetically predisposed to hair loss, these hormones can cause hair follicles to shrink, a process known as miniaturization. The EDA2R gene, which sits nearby, has been shown to activate the NF-κB signaling pathway, which is essential for the development and maintenance of hair follicles. Variations in this genomic region are thought to modulate the sensitivity of hair follicles to hormonal signals or alter the structural integrity of the follicle itself. While the exact mechanism remains a subject of ongoing investigation, the strong association between this locus and hair loss underscores the complex, polygenic nature of androgenetic alopecia.
Research Evidence and Statistical Associations
The association between the AR/EDA2R locus and androgenetic alopecia is supported by numerous genome-wide association studies (GWAS). Research has consistently identified this region as a major susceptibility factor for male-pattern baldness. While the evidence is strong, it is important to note that androgenetic alopecia is a polygenic trait, meaning it is influenced by many different genetic variants across the genome, including those on chromosome 20p11. The effect of rs1160312 is significant, but it does not act in isolation. Furthermore, most research has focused on male populations, and the genetic architecture of hair loss in women may involve different or additional factors. Because the evidence is based on statistical correlations in large cohorts, it provides a probabilistic view of risk rather than a deterministic prediction for any single individual.
Population Frequency and Interpretation
The rs1160312 variant is relatively common, with a minor allele frequency (MAF) of approximately 0.40 in European populations. This high frequency suggests that the variant is widely distributed across the population. Because it is located on the X chromosome, the inheritance pattern and the resulting impact on phenotype differ between males, who have one X chromosome, and females, who have two. When interpreting this information, it is essential to remember that genetic markers are only one piece of a much larger puzzle. Environmental factors, hormonal levels, and other genetic variants all contribute to the final expression of hair loss. Having a specific genotype at this locus does not guarantee a particular outcome, and the presence of risk alleles is common even among those who do not experience significant hair thinning.
What This Information Means for You
Understanding your genotype at rs1160312 can provide insight into your genetic predisposition for androgenetic alopecia, but it should not be used for medical diagnosis. Genetic testing for this variant is primarily for educational purposes and cannot predict the exact age of onset or the severity of hair loss. If you are concerned about hair thinning or are considering treatments, it is important to consult with a dermatologist or a qualified healthcare professional. They can provide a clinical evaluation and discuss evidence-based management options tailored to your specific needs. Avoid making health decisions based solely on genetic reports, as they do not account for the full clinical picture. Always discuss any potential medical interventions or changes to your health regimen with a clinician to ensure they are safe and appropriate for your situation.
How common is this variant?
The rs1160312 variant is common, with a minor allele frequency of approximately 0.40 in European populations.
Frequently asked questions
Does having the risk allele mean I will go bald?
No, having a risk allele does not guarantee you will experience hair loss. Hair loss is a complex, polygenic trait influenced by many genes, hormones, and environmental factors.
Is this variant only relevant for men?
While most research on this variant has focused on male-pattern baldness, the AR/EDA2R locus is also studied in the context of female-pattern hair loss. However, the genetic factors and inheritance patterns can differ significantly between sexes.
Can I change my risk based on this SNP?
You cannot change your genetic sequence. However, understanding your genetic predisposition can help you have more informed conversations with a dermatologist about preventative care or treatment options.
Should I take medication based on my rs1160312 result?
No. You should never start or change any medication based on a genetic test result. Always discuss your concerns and potential treatments with a qualified healthcare provider.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1160312?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29